BUZZ-Dexcom falls on downbeat 2024 revenue forecast

Reuters04-26

** Shares of medical device maker Dexcom fall 6.4% to $129.15

** DXCM's 2024 revenue forecast of $4.20 bln to $4.35 bln comes below Wall Street estimates of $4.32 bln at midpoint

** Co on Thursday posted Q1 adj. EPS of 32 cents, beating analysts' avg. estimate of 27 cents - LSEG

** YTD, stock down 4.1%

(Reporting by Puyaan Singh)

((Puyaan.Singh@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment